TY - JOUR
T1 - 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors
T2 - Synthesis and molecular docking study
AU - Al-Salahi, Rashad
AU - Ahmad, Rohaya
AU - Anouar, Elhassane
AU - Iwana Nor Azman, Nor Izzati
AU - Marzouk, Mohamed
AU - Abuelizz, Hatem A.
N1 - Publisher Copyright:
© 2018 2018 Newlands Press.
PY - 2018
Y1 - 2018
N2 - Aim: Using a simple modification on a previously reported synthetic route, 3-benzyl(phenethyl)-2-thioxobenzo[g]quinazolin-4(3H)-ones (1 and 2) were synthesized with high yields. Further transformation of 1 and 2 produced derivatives 3-26, which were structurally characterized based on NMR and MS data, and their in vitro α-glucosidase inhibitory activity was evaluated using Baker's yeast α-glucosidase enzyme. Results: Compounds 2, 4, 8, 12 and 20 exhibited the highest activity (IC 50 = 69.20, 59.60, 49.40, 50.20 and 83.20 μM, respectively) compared with the standard acarbose (IC 50 = 143.54 μM). Conclusion: A new class of potent α-glucosidase inhibitors was identified, and the molecular docking predicted plausible binding interaction of the targets in the binding pocket of α-glucosidase and rationalized the structure-activity relationship (SARs) of the target compounds.
AB - Aim: Using a simple modification on a previously reported synthetic route, 3-benzyl(phenethyl)-2-thioxobenzo[g]quinazolin-4(3H)-ones (1 and 2) were synthesized with high yields. Further transformation of 1 and 2 produced derivatives 3-26, which were structurally characterized based on NMR and MS data, and their in vitro α-glucosidase inhibitory activity was evaluated using Baker's yeast α-glucosidase enzyme. Results: Compounds 2, 4, 8, 12 and 20 exhibited the highest activity (IC 50 = 69.20, 59.60, 49.40, 50.20 and 83.20 μM, respectively) compared with the standard acarbose (IC 50 = 143.54 μM). Conclusion: A new class of potent α-glucosidase inhibitors was identified, and the molecular docking predicted plausible binding interaction of the targets in the binding pocket of α-glucosidase and rationalized the structure-activity relationship (SARs) of the target compounds.
KW - antidiabetic
KW - benzoquinazoline
KW - molecular docking
KW - α-glucosidase
UR - http://www.scopus.com/inward/record.url?scp=85051851796&partnerID=8YFLogxK
U2 - 10.4155/fmc-2018-0141
DO - 10.4155/fmc-2018-0141
M3 - Article
C2 - 29882426
AN - SCOPUS:85051851796
SN - 1756-8919
VL - 10
SP - 1889
EP - 1905
JO - Future Medicinal Chemistry
JF - Future Medicinal Chemistry
IS - 16
ER -